Sinopharm Tech Holdings Limited — Capital/Financing Update 2021

Aug 23, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of contents of this announcement.

This announcement appears for information only and does not constitute an invitation or offer to acquire, purchase or subscribe for the securities of the Company nor anything herein forms the basis for any contract or commitment whatsoever.

==> picture [81 x 78] intentionally omitted <==

Sinopharm Tech Holdings Limited 國藥科技股份有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8156)

SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO ISSUE OF CONVERTIBLE BONDS

Reference is made to the announcement of Sinopharm Tech Holdings Limited (the “ Company ”) dated 20 August 2021 (the “ Announcement ”) in relation to issuance of the convertible bonds of an aggregate principal amount of HK$100,000,000. Terms used herein shall have the same meanings as those defined in the Announcement unless otherwise specified.

The Board wishes to provide the Shareholders and potential investors of the Company with additional information on the identity of the ultimate beneficial owner of Expert Global Enterprises Limited, being the First Subscriber and Japan Equity Value Investment Fund, being the Second Subscriber. To the best of the Directors’ knowledge, information and belief and having made all reasonable enquiries, the ultimate beneficial owner of the First Subscriber is Kingkey Financial International (Holdings) Limited, which is listed on the Stock Exchange with stock code 1468; and the ultimate beneficial owner of the Second Subscriber is Mr. CHAN Chuck Yiu Michael.

The additional information above does not affect any information set out in the Announcement. Saved as disclosed above, all other information contained in the Announcement remains unchanged and shall continue to be valid for all purposes.

By Order of the Board Sinopharm Tech Holdings Limited 國藥科技股份有限公司 CHAN Ting Chairperson

Hong Kong, 23 August 2021

• 1 -

As at the date of this announcement, the Board comprises Mr. CHAN Ting, Mr. LIAO Zhe and Mr. CHEUK Ka Chun Kevin as executive Directors, Madam CHEUNG Kwai Lan and Dr. CHENG Yanjie as nonexecutive Directors and Mr. LAU Fai Lawrence, Dr. LIU Ta-pei and Mr. CHAU Wai Wah Fred as independent non-executive Directors.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the “Latest Listed Company Information” page of the GEM website at www.hkgem.com for a minimum period of 7 days from the date of its publication and on the website of the Company at www.sinopharmtech.com.hk.

• 2 -